Versant Capital Management’s Viridian Therapeutics VRDN Stock Holding History

Versant Capital Management’s Portfolio VRDN Stock Details VRDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$2.89K	Hold
2025 Q2	$1.87K	Sell
2025 Q1	$4.22K	Buy
2024 Q4	$1.57K	Buy